DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Influenza Diagnostics Market By Test Type, By End Use And Segment Forecasts To 2024" report to their offering.
The influenza diagnostics market is expected to reach USD 3.3 billion by 2024. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally.
The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC's seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.
Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.
Companies Mentioned:
- Becton, Dickinson and Company
- Quidel Corporation
- Roche
- Sekisui Diagnostics, LLC
- SA Scientific Ltd.
- Meridian Bioscience, Inc.
- Thermo Fisher Scientific
- 3M Health Care
- Alere
Report Structure:
1 Research Methodology & Scope
2 Executive Summary
3 Market Snapshot
4 Market Variables, Trends& Scope
5 Market Categorization 1: Test Type Estimates & Trend Analysis
6 Market Categorization 2: End-use Estimates & Trend Analysis
7 Market Categorization 3: Regional Estimates & Trend Analysis, by Application and Technology
8 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/rlh23h/influenza
